← back to search

Kepeng Wang

Guangzhou University of Chinese Medicine · CN
Area of research
Cell Biology · Oncology
Research interest
Research interests include Endoplasmic Reticulum Stress and Disease, Psoriasis: Treatment and Pathogenesis, Cancer Immunotherapy and Biomarkers, and Cytokine Signaling Pathways and Interactions.
h-index
26
citations
5,245
works
99
NIH funding
primary concept
email

Recent publications

The role of interleukin-17 in inflammation-related cancers
Frontiers in Immunology 2025cited by 46position: middledoi
Toward precision medicine in COPD: phenotypes, endotypes, biomarkers, and treatable traits
Respiratory Research 2025cited by 28position: middledoi
CARG-2020 targets IL-12, IL-17, and PD-L1 pathways to effectively treat melanoma and breast cancer
Scientific Reports 2025cited by 2position: lastdoi
Mechanoelectronic stimulation of autologous extracellular vesicle biosynthesis implant for gut microbiota modulation
Nature Communications 2024cited by 32position: middledoi
Interleukin-17 directly stimulates tumor infiltrating Tregs to prevent cancer development
Frontiers in Immunology 2024cited by 14position: lastdoi
Cancer immunotherapy with enveloped self-amplifying mRNA CARG-2020 that modulates IL-12, IL-17 and PD-L1 pathways to prevent tumor recurrence
Acta Pharmaceutica Sinica B 2023cited by 18position: lastdoi
Multiple methods for the identification of heavy metal sources in cropland soils from a resource-based region
The Science of The Total Environment 2018cited by 248position: middledoi
YAP–IL-6ST autoregulatory loop activated on APC loss controls colonic tumorigenesis
Proceedings of the National Academy of Sciences 2017cited by 95position: middledoi
Intestinal NCoR1, a regulator of epithelial cell maturation, controls neonatal hyperbilirubinemia
Proceedings of the National Academy of Sciences 2017cited by 24position: middledoi
A gp130–Src–YAP module links inflammation to epithelial regeneration
Nature 2015cited by 627position: middledoi
Tumor-Elicited Inflammation and Colorectal Cancer
Advances in cancer research 2015cited by 161position: firstdoi
Interleukin-17 Receptor A Signaling in Transformed Enterocytes Promotes Early Colorectal Tumorigenesis
Immunity 2014cited by 336position: firstdoi
MiR-124 Suppresses Growth of Human Colorectal Cancer by Inhibiting STAT3
PLoS ONE 2013cited by 123position: middledoi
Intestinal glucuronidation protects against chemotherapy-induced toxicity by irinotecan (CPT-11)
Proceedings of the National Academy of Sciences 2013cited by 117position: middledoi
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Nature 2012cited by 1,302position: middledoi
Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases
Annals of the Rheumatic Diseases 2012cited by 73position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Michael Karin · Discovery Institute8 papers (2012–2017)Koji Taniguchi · Hokkaido University of Science4 papers (2012–2017)Sergei I. Grivennikov · Cedars-Sinai Medical Center4 papers (2012–2015)Ju Chen · Foshan Hospital of TCM3 papers (2023–2025)Eric R. Fearon · Michigan Cancer Research Consortium3 papers (2012–2017) · 2 papers (2023–2025) · 2 papers (2023–2025)Mei‐Fei Yueh · University of California San Diego2 papers (2013–2017)Petrus R. de Jong · San Diego Fertility Center2 papers (2015–2017) · 2 papers (2023–2025) · 2 papers (2023–2025)Kun‐Liang Guan · Westlake University2 papers (2015–2017)Li‐Wha Wu · Kaohsiung Medical University2 papers (2014–2015)Jun Wan · Jiangnan University2 papers (2013–2014)Shujuan Chen · The University of Texas MD Anderson Cancer Center2 papers (2013–2017)Timur O. Yarovinsky · Brown University2 papers (2023–2025) · 2 papers (2025–2025)Robert H. Tukey · University of California San Diego2 papers (2013–2017)Bhaskara Reddy Madina · Texas A&M University2 papers (2023–2025)Xiaoyang Ye · Princeton University2 papers (2023–2025)